Clinical Trial Update: Psilocybin for Treatment-Resistant Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on psilocybin for treatment-resistant major depressive disorder; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Major Depressive Disorder, Anhedonia | Phase 2 | Status: ACTIVE_NOT_RECRUITING